Skip to content

United Therapeutics Corp

UTHR· NasdaqCore metricsCIK 1082554

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.34%
Market cap
$25.27B
42.59M shares
Filings
1,223
$832.50M
Q3 2026+10.6% FY25 yoy
$258.60M
Q3 2026+11.7% FY25 yoy
$307.80M
Q3 2026+8.4% FY25 yoy
$693.90M
Q3 2026derived−3.7% FY25 yoy
$5.71
Q3 2026+13.1% FY25 yoy
$1.19B
Q3 2026−8.3% FY25 yoy
$25.27B
20.5×
7.9×
4.0×
3.43%
—

Twelve months to Sep 30, 2026 · derived

Price

$593.45+29.40%+$134.82past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$3.18BFY 2025
$3.18B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$3,182,700,000reported
FY 20242024-12-31$2,877,400,000reported
FY 20232023-12-31$2,327,500,000reported
FY 20222022-12-31$1,936,300,000reported
FY 20212021-12-31$1,685,500,000reported
FY 20202020-12-31$1,483,300,000reported
FY 20192019-12-31$1,448,800,000reported
FY 20182018-12-31$1,627,800,000reported
FY 20172017-12-31$1,725,300,000reported
FY 20162016-12-31$1,598,800,000reported
FY 20152015-12-31$1,465,800,000reported
FY 20142014-12-31$1,288,500,000reported

Capital returns

Dividends and buybacks · FY2012 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$1.00B$1.00B—43.83M sh−2.4%96.1%
FY2024—$1.00B$1.00B—44.91M sh−4.6%92.5%
FY2023—$0.00$0.00—47.06M sh+1.6%0.0%
FY2022—$0.00$0.00—46.30M sh+2.6%0.0%
FY2017—$250.00M$250.00M—43.24M sh−3.8%64.4%

Segments

Revenue by Geography, FY2019 to FY2025FY2019United States · FY2019 · $1.32BRest-of-World · FY2019 · $125.60MFY2020United States · FY2020 · $1.41BRest-of-World · FY2020 · $71.20MFY2021United States · FY2021 · $1.56BRest-of-World · FY2021 · $121.30MFY2022United States · FY2022 · $1.81BRest-of-World · FY2022 · $122.20MFY2023United States · FY2023 · $2.20BRest-of-World · FY2023 · $125.30MFY2024United States · FY2024 · $2.74BRest-of-World · FY2024 · $137.70MFY2025United States · FY2025 · $3.04BRest-of-World · FY2025 · $145.70M
LineFY2025ShareChange
United States$3.04B95%+10.9%
Rest-of-World$145.70M4.6%+5.8%
Total$3.18B

From the 10-K filed Feb 25, 2026UTHR

Pharmaceutical preparations

United Therapeutics Corp is the 24th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

United Therapeutics Corp · CIK 1082554 · Engraved from SEC EDGAR